When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Síndrome do olho seco

Last reviewed: 8 Dec 2025
Last updated: 19 Jun 2025

Summary

Definition

History and exam

Key diagnostic factors

  • causa clínica subjacente conhecida
  • uso de medicamentos causadores conhecidos
  • filamentos corneanos
Full details

Other diagnostic factors

  • irritação ocular/sensação de corpo estranho
  • ardência ocular
  • visão turva transitória
  • lacrimejamento
  • blefarite/meibomianite
  • erosões epiteliais pontuadas
  • erosões conjuntivais ponteadas
  • hiperemia conjuntival
  • lagoftalmia
  • proptose
  • presença de ácaros
Full details

Risk factors

  • sexo feminino
  • idade avançada
  • blefarite/meibomianite
  • doenças do tecido conjuntivo
  • deficiência de vitamina A
  • hepatite C
  • vírus da imunodeficiência humana (HIV)
  • transplante de células-tronco hematopoéticas
  • cirurgia do cristalino e das pálpebras
  • uso de lentes de contato
  • diabetes mellitus
  • medicamentos sistêmicos
  • medicamentos oftálmicos tópicos preservados
  • sarcoidose
  • Doença de Parkinson
  • fatores ambientais
  • fatores ocupacionais
  • cefaleia
Full details

Diagnostic investigations

1st investigations to order

  • altura do menisco do filme lacrimal (meniscometria)
  • tempo de ruptura do filme lacrimal/fluoresceína (TRFL)
  • teste de Schirmer
Full details

Emerging tests

  • osmometria do filme lacrimal
  • detecção da metaloproteinase-9 (MMP-9)
  • topografia corneana
  • interferometria da superfície ocular
  • termografia infravermelha
  • microscopia confocal in vivo
  • marcadores imunes da superfície ocular (OSIM)

Treatment algorithm

ACUTE

olho seco na apresentação inicial

ONGOING

olho seco crônico

Contributors

Authors

Jonathan Smith, FRCOphth, MRCP

Consultant Ophthalmologist

Sunderland Eye Infirmary

Sunderland

UK

Divulgaciones

JS declares that he has no competing interests.

Philip Severn, FRCOphth, MRCP

Consultant Ophthalmologist

James Cook University Hospital

Middlesbrough

UK

Divulgaciones

PS declares that he has served on the advisory boards of and received travel grants from Bayer and Novartis. He has also received travel grants from Allergan.

Darren Shu Jeng Ting, FRCOphth, PhD

Honorary Associate Professor of Ophthalmology

School of Medicine

University of Nottingham

Consultant Ophthalmologist

Birmingham and Midland Eye Centre

UK

Divulgaciones

DSJT declares that he has no competing interests.

Saurabh Ghosh, FRCOphth

Consultant Ophthalmologist

Sunderland Eye Infirmary

Sunderland

UK

Divulgaciones

SG declares that he has no competing interests.

Revisores por pares

I-Hui Wu, MD

Ophthalmology Resident

Wilmer Eye Institute

Baltimore

MD

Divulgaciones

IW declares that she has no competing interests.

Gus Gazzard, MA, MBBChir, MD, FRCOphth

Consultant Ophthalmic Surgeon

King's College Hospital

Honorary Research Fellow

Institute of Ophthalmology

London

UK

Divulgaciones

GG declares that he has no competing interests.

Bob Avery, MD, PhD

Assistant Professor

Ophthalmology

University of New Mexico Medical School

Albuquerque

NM

Divulgaciones

BA declares that he has no competing interests.

Vatinee Y. Bunya, MD

Co-Director

Penn Dry Eye and Ocular Surface Center

Assistant Professor

Cornea and External Disease

Scheie Eye Institute

Philadelphia

PA

Divulgaciones

VYB declares that she has no competing interests.

Agradecimiento de los revisores por pares

Los temas de BMJ Best Practice se actualizan de forma continua de acuerdo con los desarrollos en la evidencia y en las guías. Los revisores por pares listados aquí han revisado el contenido al menos una vez durante la historia del tema.

Divulgaciones

Las afiliaciones y divulgaciones de los revisores por pares se refieren al momento de la revisión.

Referencias

Nuestros equipos internos de evidencia y editoriales colaboran con colaboradores expertos internacionales y revisores pares para garantizar que brindemos acceso a la información más clínicamente relevante posible.

Artículos principales

Hakim FE, Farooq AV. Dry eye disease: an update in 2022. JAMA. 2022 Feb 1;327(5):478-9. Resumen

Amescua G, Ahmad S, Cheung AY, et al. Dry eye syndrome preferred practice pattern®. Ophthalmology. 2024 Apr;131(4):P1-49.Texto completo  Resumen

Craig JP, Nichols KK, Akpek EK, et al. TFOS DEWS II definition and classification report. Ocul Surf. 2017 Jul;15(3):276-83.Texto completo  Resumen

Shtein RM, Shen JF, Kuo AN, et al. Autologous serum-based eye drops for treatment of ocular surface disease: a report by the American Academy of Ophthalmology. Ophthalmology. 2020 Jan;127(1):128-33.Texto completo  Resumen

Artículos de referencia

Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.

El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad